Dedicated to primary cells
Product and service development

Dedicated to the development of primary cell products and services

Learn More
Primary Cells, Pharmacological Efficacy Services, and Product Services
One-Stop Expert in Upstream Cell Solutions

Expert in one-stop upstream cell solutions for primary cells, drug efficacy services, and product services

Learn More
Integrating the "Sample–Technology–Product" Innovation Chain
Driving the Future of Science through a Closed-Loop Ecosystem

Closing the Loop from Biospecimens to Products — Driving Innovation in Life Sciences

Learn More
scroll down

About Us

Dedicated to primary cells
Product and Service Development

Hycells Biotechnology Co., Ltd. is an innovative biotechnology company specializing in primary cells, related reagents, and technical services. With a long-standing commitment to the fields of cell and gene therapy (CGT) and large-molecule therapeutics, the team is dedicated to providing customers with end-to-end, one-stop solutions for primary cell products—covering research and development, manufacturing, sales, and technical support.

View more

Product Center

Quality first, innovation oriented

Cultivation Products

.

Culture products generally refer to various reagents, consumables and equipment used for in vitro culture, expansion and maintenance of cells, and are widely used in scientific research, drug development, vaccine production, cell therapy and other fields.

Obtain Solutions →

Testing Products

.

Hycells is committed to becoming a leading global one-stop supplier of primary cells, related reagents, and services.

Obtain Solutions →

Other Products And Instruments

.

Hycells is committed to becoming a leading global one-stop supplier of primary cells, related reagents, and services.

Obtain Solutions →

Cultivation Products

Cultivation Products

Testing Products

Testing Products

Other Products And Instruments

Other Products And Instruments

Our Advantages

Primary Cells, Pharmacological Efficacy Services, and Product Services
One-Stop Expert in Upstream Cell Solutions

Quality

High-quality technical standards

Professional

Professional laboratory research team

Compliance

Clinical Sample Collection Compliance System

After-sales

A comprehensive after-sales service system

News Updates

Stay updated on Hycells’ latest news

Hycell’s maximum production capacity per batch is 200–400 units of the 500 mL format, ensuring stable supply and meeting customers’ ongoing production needs.

The blood‑derived raw materials used in HiXpan® cell culture additives comply with all regulatory requirements throughout collection, ethical review, informed consent, and commercial authorization, and are supported by a fully traceable supply chain.

This paper focuses on how Hycells transforms biological variability into engineering‑level determinism through a scientifically informed blending strategy and stringent control at the collection end.

Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.

This article will examine how Hycells proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.

In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.

Quickly access products and solutions

Currently, Hycells has established nearly 1,000 square meters of R&D laboratories and has officially obtained GB/T 19001-2016/ISO 9001:2015 quality management system certification. The company has also been recognized as a “Shanghai High-Tech Enterprise” and a “Shanghai Specialized, Sophisticated, Distinctive, and Innovative SME.” Hycells is committed to becoming a world-leading one-stop supplier of primary cells, associated reagents, and related services.